Welander Distal Myopathy Caused by an Ancient Founder Mutation in TIA1 Associated with Perturbed Splicing

Welander distal myopathy (WDM) is an adult onset autosomal dominant disorder characterized by distal limb weakness, which progresses slowly from the fifth decade. All WDM patients are of Swedish or Finnish descent and share a rare chromosome 2p13 haplotype. We restricted the WDM‐associated haplotype followed by whole exome sequencing. Within the conserved haplotype, we identified a single heterozygous mutation c.1150G>A (p.E384K) in T‐cell intracellular antigen‐1 (TIA1) in all WDM patients investigated (n = 43). The TIA1 protein regulates splicing, and translation through direct interaction with mRNA and the p.E384K mutation is located in the C‐terminal Q‐rich domain that interacts with the U1‐C splicing factor. TIA1 has been shown to prevent skipping of SMN2 exon 7, and we show that WDM patients have increased levels of spliced SMN2 in skeletal muscle cells when compared with controls. Immunostaining of WDM muscle biopsies showed accumulation of TIA1 and stress granulae proteins adjacent to intracellular inclusions, a typical finding in WDM. The combined findings strongly suggest that the TIA1 mutation causes perturbed RNA splicing and cellular stress resulting in WDM. The selection against the mutation is likely to be negligible and the age of the TIA1 founder mutation was calculated to approximately 1,050 years, which coincides with the epoch of early seafaring across the Baltic Sea.

[1]  B. Udd Distal myopathies – New genetic entities expand diagnostic challenge , 2012, Neuromuscular Disorders.

[2]  L. Welander Myopathia distalis tarda hereditaria; 249 examined cases in 72 pedigrees. , 1951, Acta medica Scandinavica. Supplementum.

[3]  J. Jenkins,et al.  Three RNA recognition motifs participate in RNA recognition and structural organization by the pro-apoptotic factor TIA-1. , 2012, Journal of molecular biology.

[4]  E. Kuusisto,et al.  Use of p62/SQSTM1 antibodies for neuropathological diagnosis , 2008, Neuropathology and applied neurobiology.

[5]  M. Boehnke,et al.  Limits of resolution of genetic linkage studies: implications for the positional cloning of human disease genes. , 1994, American journal of human genetics.

[6]  A. Chapelle,et al.  Disease gene mapping in isolated human populations: the example of Finland. , 1993, Journal of medical genetics.

[7]  E. Lander,et al.  ARSACS, a spastic ataxia common in northeastern Québec, is caused by mutations in a new gene encoding an 11.5-kb ORF , 2000, Nature Genetics.

[8]  Eric S. Lander,et al.  The diastrophic dysplasia gene encodes a novel sulfate transporter: Positional cloning by fine-structure linkage disequilibrium mapping , 1994, Cell.

[9]  C. Bruder,et al.  Refined mapping of the Welander distal myopathy region on chromosome 2p13 positions the new candidate region telomeric of the DYSF locus , 2003, Neurogenetics.

[10]  C. Damgaard,et al.  Translational coregulation of 5'TOP mRNAs by TIA-1 and TIAR. , 2011, Genes & development.

[11]  R. Zechner,et al.  Mutations in the fatty acid transport protein 4 gene cause the ichthyosis prematurity syndrome. , 2009, American journal of human genetics.

[12]  E. Ottesen,et al.  TIA1 Prevents Skipping of a Critical Exon Associated with Spinal Muscular Atrophy , 2010, Molecular and Cellular Biology.

[13]  C. Lorson,et al.  Spinal muscular atrophy: mechanisms and therapeutic strategies. , 2010, Human molecular genetics.

[14]  Pieter J. de Jong,et al.  Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy , 1998, Nature Genetics.

[15]  G. Rouleau,et al.  TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. , 2011, Human molecular genetics.

[16]  D. Baralle,et al.  Novel roles of U1 snRNP in alternative splicing regulation , 2010, RNA biology.

[17]  L. Edström,et al.  Welander distal myopathy outside the Swedish population: phenotype and genotype , 2002, Neuromuscular Disorders.

[18]  W. Engel,et al.  In sporadic inclusion body myositis muscle fibres TDP‐43‐positive inclusions are less frequent and robust than p62 inclusions, and are not associated with paired helical filaments , 2011, Neuropathology and applied neurobiology.

[19]  A. Hedström,et al.  Inclusion body myositis and welander distal myopathy: a clinical, neurophysiological and morphological comparison , 1991, Journal of the Neurological Sciences.

[20]  K. Duff,et al.  Contrasting Pathology of the Stress Granule Proteins TIA-1 and G3BP in Tauopathies , 2012, The Journal of Neuroscience.

[21]  W. Seeger,et al.  TIAR and TIA-1 mRNA-binding proteins co-aggregate under conditions of rapid oxygen decline and extreme hypoxia and suppress the HIF-1α pathway. , 2010, Journal of molecular cell biology.

[22]  M. Komatsu,et al.  Physiological significance of selective degradation of p62 by autophagy , 2010, FEBS letters.

[23]  Bjarne Udd,et al.  Welander distal myopathy is caused by a mutation in the RNA‐binding protein TIA1 , 2013, Annals of neurology.

[24]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[25]  L. Edström,et al.  Genetic linkage of Welander distal myopathy to chromosome 2p13 , 1999, Annals of neurology.

[26]  R. Griggs Overview of distal myopathies: from the clinical to the molecular , 1997, Neuromuscular Disorders.

[27]  P. Anderson,et al.  RNA granules: post-transcriptional and epigenetic modulators of gene expression , 2009, Nature Reviews Molecular Cell Biology.

[28]  J. Lykke-Andersen,et al.  Cytoplasmic mRNP granules at a glance , 2011, Journal of Cell Science.